Ra Medical Systems, Inc. Soared
Ra Medical Systems, Inc. (RMED:NYSE) soared at $1.23, a gain of 38.5%. From Fri 06 Dec 19, the stock recorded 35.71% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Ra Medical Systems, Inc. (RMED:NYSE)
Ra Medical Systems Inc is a commercial-stage medical device company. It is engaged in designing, developing, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company's products include DABRA and Pharos. DABRA System is an effective, and versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels, and the Pharos is a monochromatic, xenon-chlorine, 308-nm UVB excimer laser for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Its business segments are the Dermatology segment and the Vascular segment. Generating, its revenue from the Dermatology segment.
Top 10 Gainers:
- Savara Inc. (SVRA:NASDAQ), 183.82%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 61.28%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 58.18%
- NIO Inc. (NIO:NYSE), 53.72%
- Ocugen, Inc. (OCGN:NASDAQ), 44.75%
- Ra Medical Systems, Inc. (RMED:NYSE), 38.52%
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 37.94%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 36.27%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 32.28%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 31.04%